{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:10:31Z","timestamp":1790179831997,"version":"4.1.0"},"reference-count":23,"publisher":"Informa UK Limited","issue":"23","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Helsinn Healthcare SA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.2217\/fon-2021-0023","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T08:12:23Z","timestamp":1618992743000},"page":"3027-3035","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Single-Dose Netupitant\/Palonosetron Versus 3-day Aprepitant for Preventing Chemotherapy-Induced Nausea and Vomiting: A Pooled Analysis"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8513-896X","authenticated-orcid":false,"given":"Rudolph M","family":"Navari","sequence":"first","affiliation":[{"name":"World Health Organization Cancer Care Program,\rBirmingham, AL35211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Binder","sequence":"additional","affiliation":[{"name":"Helsinn Therapeutics,\rIselin, NJ08830, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminio","family":"Bonizzoni","sequence":"additional","affiliation":[{"name":"Department of Clinical Science & Community, Section of Medical Statistics, Biometry & Epidemiology \u201cG.A. Maccacaro\u201d,University of Milan,\rMilan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Clark-Snow","sequence":"additional","affiliation":[{"name":"Oncology Supportive Care Consultant,\rOverland Park, KS66212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Olivari","sequence":"additional","affiliation":[{"name":"Helsinn Healthcare,\rLugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J","family":"Roeland","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center,Massachusetts General Hospital,\rBoston, MA02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01296"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw270"},{"key":"e_1_3_7_5_1","unstructured":"NCCN . National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Antiemesis. Version 2.2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf"},{"key":"e_1_3_7_6_1","unstructured":"Akynzeo\u00ae prescribing information. Helsinn Birex Pharmaceuticals Ltd Dublin Ireland (2018)."},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu110"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu101"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx698"},{"key":"e_1_3_7_10_1","unstructured":"Zelek L DebourdeauP BourgeoisHet al. A pragmatic randomized study evaluating the comparative effectiveness of NEPA and the standard-of-care aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC). (2020). medias.sfspm.org\/Nice-2020\/AbstractPDF\/25dcbd45-9ec2-40f3-ebe0-5f1ed960af14\/"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu096"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0737-9"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80075-9"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12685"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv138"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3585-z"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.095"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11433"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl019"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901213400304"},{"key":"e_1_3_7_21_1","unstructured":"Emend\u2122 prescribing information. Merck & Co NJ USA (2020)."},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2005.03.007"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1448-1"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0187"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2018-0089"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:47:07Z","timestamp":1719125227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":23,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.2217\/fon-2021-0023"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0023","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}